Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM News Today.
Press releases published on May 15, 2025

Stationary Patient Room Pressure Monitor Market Trends, Growth and Forecast to 2034 | Exactitude Consultancy
Luton, Bedfordshire, United Kingdom, May 15, 2025 (GLOBE NEWSWIRE) -- The global stationary patient room pressure monitor market is on a robust growth trajectory, fueled by rising healthcare infrastructure development, heightened infection control …

N2OFF Energy Targets European’s Energy Crises with Fourth Regional Battery Project
N2OFF to take part in financing a 35MW/140MWh planned Battery Energy Storage System project in Poland Neve Yarak, Israel, May 15, 2025 (GLOBE NEWSWIRE) -- N2OFF, Inc.(NASDAQ: NITO) (FSE:80W) (“N2OFF” and the “Company”), a clean tech company engaged in …

New FTI Consulting Survey Reveals Mounting Challenges Continue for U.S. Hospitals
WASHINGTON, May 15, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced findings from its annual Hospital Operations Outlook Survey of more than 200 senior executives across all types of hospitals. The survey found rising costs, …

Echo Launches Worldwide and Starts Exclusive Public Sale for the ECHO Token
Douglas, Isle of Man, May 15, 2025 (GLOBE NEWSWIRE) -- Echo, a revolutionary centralized crypto exchange, officially launched worldwide on May 15, marking a historical event for the digital asset trading landscape. On the same day, the platform started …

Skyharbour and JV Partner Orano to Commence Extensive Summer 2025 Drilling Program at Preston Uranium Project
Vancouver, BC, May 15, 2025 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour” or the “Company”), is pleased to announce that its joint-venture partner, Orano Canada Inc. (“Orano”), will commence a …

Abeona Therapeutics® Reports First Quarter 2025 Financial Results and Corporate Updates
- Received approval by U.S. Food and Drug Administration (FDA) for ZEVASKYN™ (prademagene zamikeracel), the first and only autologous cell-based gene therapy for the treatment of wounds in adult and pediatric patients with recessive dystrophic …

ZenaTech Reports Nearly Double Revenue Year-Over-Year for the First Quarter of 2025
VANCOUVER, British Columbia, May 15, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology company specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS and Quantum …

Avicanna Reports Q1 2025 Results and First Profitable Quarter
TORONTO, May 15, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based …

PyroGenesis Confirms Successful Collection of Material from Fumed Silica Pilot Plant Baghouse
MONTREAL, May 15, 2025 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (“PyroGenesis”) (http://pyrogenesis.com) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a high-tech company that designs, develops, manufactures and commercializes all-electric plasma processes and …

Digi Power X Reports 65% Increase in Q1 2025 Revenue Over Prior Quarter With no Long-Term Debt
MIAMI, May 15, 2025 (GLOBE NEWSWIRE) -- Digi Power X Inc. (“Digi Power X” or the “Company”) (Nasdaq: DGXX / TSXV: DGX), a vertically integrated power infrastructure company focused on developing cutting-edge data centers for high-performance computing, is …

LeddarTech gibt Einführung von LeddarSim bekannt: Der nächste Quantensprung in der realistischen Simulation von Fahrerassistenzsystemen (Realistic Advanced Driver Assistance System, ADAS) und autonomem Fahren (Autonomous Driving, AD)
QUEBEC CITY, Kanada, May 15, 2025 (GLOBE NEWSWIRE) -- LeddarTech® Holdings Inc. („LeddarTech“) (Nasdaq: LDTC), ein auf KI-Technologie spezialisiertes Softwareunternehmen, das für seine Innovationen im Bereich fortschrittlicher Fahrerassistenzsysteme (ADAS) …

レダーテック (LeddarTech)、LeddarSimのリリースを発表:現実的な先進運転支援システム (ADAS) と自動走行 (AD) シミュレーションにおける次の飛躍
カナダ・ケベックシティ発, May 15, 2025 (GLOBE NEWSWIRE) -- 先進運転支援システム (ADAS) と自動運転 (AD) の革新で知られる、AIを活用したソフトウエア企業であるレダーテック・ホールディングス (LeddarTech® Holdings Inc.) (「レダーテック」) (NASDAQ: LDTC) は、バーチャルテストと実世界での展開のギャップを縮めることを目的に構築された次世代シミュレーションプラットフォーム、LeddarSim™のリリースを発表した。 …

LeddarTech 宣布推出 LeddarSim,实现逼真高级驾驶辅助系统和自动驾驶仿真领域的又一次重大飞跃
魁北克市,加拿大, May 15, 2025 (GLOBE NEWSWIRE) -- LeddarTech® Holdings Inc.(以下简称“LeddarTech”,Nasdaq:LDTC)是一家人工智能驱动的软件公司,因其在高级驾驶辅助系统 (ADAS) 和自动驾驶 (AD) 领域的创新而享有盛誉。公司现欣然宣布推出全新一代仿真平台 LeddarSim™,旨在缩小虚拟测试与实际部署之间的差距。 LeddarSim …

Surfshark expands Dedicated IP with new locations
Surfshark, a cybersecurity company, expands its Dedicated IP service to seven new locations, now offering unique, static IP (Internet Protocol) addresses in 20 locations worldwide. This expansion provides users with reliable access to IP-sensitive services …

Hospital Logistics Distribution Robots Market Outlook, Trends, Growth and Innovations | Exactitude Consultancy
Luton, Bedfordshire, United Kingdom, May 15, 2025 (GLOBE NEWSWIRE) -- The global Hospital Logistics Distribution Robot market is witnessing remarkable growth, driven by increasing demand for automation and efficiency in healthcare logistics. Valued at …

US Rare Cancer Market FDA Approved Rare Cancer Drug Clinical Trials Insight
Delhi, May 15, 2025 (GLOBE NEWSWIRE) -- US Orphan Designated Drugs Market Opportunity, Drugs Sales, Price, Dosage and Clinical Trials Insight 2030 Report Offering and Highlights: US Orphan Designated Drugs Market Opportunity: > US$ 190 Billion By 2030 …

Kraig Biocraft Laboratories Receives Business License to Begin Operations in Cambodia
ANN ARBOR, Mich., May 15, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), a world leader in spider silk technology*, announces today that it has officially received its business license to begin …

Zenas BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Updates
- Topline results from pivotal Phase 3 INDIGO trial in Immunoglobulin G4-Related Disease expected around year-end 2025 - - Phase 2 MoonStone trial in Relapsing Multiple Sclerosis enrollment concluding; topline results expected early in the fourth quarter …

SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization
Salt Lake City, UT , May 15, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT), an advanced ceramics company pioneering medical and antipathogenic applications of silicon nitride (Si₃N₄), today provided a comprehensive update on its …

Microchip Brings Hardware Quantum Resistance to Embedded Controllers
CHANDLER, Ariz., May 15, 2025 (GLOBE NEWSWIRE) -- Driven by advancements in cryptographic research and the need for stronger security measures, the National Security Agency (NSA) introduced the Commercial National Security Algorithm Suite 2.0 (CNSA 2.0) to …